Q2 2020 Holdings
Filed 2020-07-16 | 94 holdings | $104.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $29.5M | 300,000 | 28.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $23.4M | 190,000 | 22.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $14.9M | 234,378 | 14.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $14.4M | 410,000 | 13.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.2M | 62,095 | 8.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $4.8M | 90,000 | 4.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.5M | 17,000 | 4.4% |
| Cellectis S A(CLLS) | SPONS ADS | 15117K103 | $2.6M | 144,604 | 2.5% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $41.7K | 750,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $39.9K | 137,500 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $31.0K | 105,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $22.3K | 380,000 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $22.2K | 375,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $21.8K | 425,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $21.3K | 190,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $21.3K | 55,000 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $20.6K | 110,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $18.8K | 675,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $18.3K | 790,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $17.7K | 230,000 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $17.2K | 105,000 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $17.1K | 65,000 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $16.9K | 185,000 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $16.5K | 470,000 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $16.4K | 68,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $16.3K | 460,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $15.5K | 160,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $15.4K | 210,000 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $15.1K | 137,032 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $15.0K | 185,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $14.8K | 155,000 | 0.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $14.7K | 227,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $13.3K | 210,778 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $12.7K | 75,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $12.4K | 160,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $12.2K | 475,000 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $12.0K | 130,780 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.4K | 100,000 | 0.0% |
| Cooper COS Inc | COM NEW | 216648402 | $11.3K | 40,000 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $10.6K | 220,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $10.4K | 500,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $9.7K | 17,000 | 0.0% |
| Livongo Health Inc(LVGO) | SHS | 539183103 | $9.4K | 125,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $9.3K | 340,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.2K | 75,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $8.7K | 590,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $8.4K | 260,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $8.3K | 120,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $8.2K | 925,534 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $8.2K | 95,000 | 0.0% |